A research group from St.Petersburg Polytechnic University led by Professor Andrei Kozlov has published their study’s findings regarding HIV vaccine creation.
Ever heard of the dangers of kissing? The infection termed as ‘kissing disease’ is a viral infection which spreads through saliva which is where it gets its name from.
The DTP vaccine (diphtheria, tetanus, and pertussis – used to treat whooping cough), particularly two batches of it, were recalled in October 2017 as they tested unsuccessful, as per the British Columbia Centre for Disease Control.
Silencing an earlier known protein could hamper tumor development and increase the efficacy of immunotherapy treatments, researchers discovered at the Bloomberg~Kimmel Institute for Cancer Immunotherapy in the Johns Hopkins Kimmel Cancer Center.
New research funded by the NIH found that a second-generation drug, when injected in rodents, deferred signs of amyotrophic lateral sclerosis (ALS).
Clinical Innovations has launched its new subsidiary in Shanghai to grow in the Chinese labor and delivery market, expanding its global footprint.
HiFiBiO Therapeutics is aspiring to work on antibody therapies for different gastrointestinal diseases, cancers and other disorders by signing a pact with Japanese Pharma and biotech company Takeda.
$7.6 million has been granted to SkinVision, an Amsterdam-based skin cancer screening app, as backing from active investors Leo Pharma and PHS Fund, with supplementary aid from unnamed new sponsors which the company called "high net worth impact investors."
Phillips-Medisize introduced a connected health platform to enhance the way people take medication while using connected health devices.
The condition of memory loss is termed as Alzheimer’s disease, affecting more than 5 million people and there is still no definite cure. A research team reported that an experimental drug could treat Alzheimer’s disease by slowing down the process of clear thinking and memory.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.